ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

ClinicalTrials.gov ID: NCT04410796

Public ClinicalTrials.gov record NCT04410796. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized Study of Osimertinib Versus Osimertinib Plus Chemotherapy for Patients With Metastatic EGFR-Mutant Lung Cancers That Have Detectable EGFR-Mutant cfDNA in Plasma After Initiation of Osimertinib

Study identification

NCT ID
NCT04410796
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Enrollment
571 participants

Conditions and interventions

Interventions

  • Carboplatin Drug
  • Osimertinib Drug
  • Pemetrexed Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 27, 2020
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026
Last update posted
Nov 5, 2025

2020 – 2026

United States locations

U.S. sites
18
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
UC Davis Cancer Center (Data Collection Only) Sacramento California 95817 Recruiting
University of California San Francisco San Francisco California 94143 Active, not recruiting
Moffitt Cancer Center Tampa Florida 33612 Recruiting
John Hopkins Medical Center Baltimore Maryland 21287 Recruiting
Massachusetts General Hospital (Data Collection Only) Boston Massachusetts 02114 Recruiting
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey 07920 Recruiting
Hackensack Meridian Health Hackensack New Jersey 07601 Recruiting
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown New Jersey 07748 Recruiting
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey 07645 Recruiting
Memorial Sloan Kettering Commack (Limited protocol activities) Commack New York 11725 Recruiting
Memorial Sloan Kettering Westchester (Limited protocol activities) Harrison New York 10604 Recruiting
New York University New York New York 10010 Recruiting
Columbia University (Data Collection Only) New York New York 10032 Active, not recruiting
Memorial Sloan Kettering Cancer Center (All protocol activities) New York New York 10065 Recruiting
Memorial Sloan Kettering Nassau (Limited Protocol Activities) Uniondale New York 11553 Recruiting
Sarah Cannon Research Institute Nashville Tennessee 37203 Recruiting
MD ANDERSON CANCER CENTER (Data Collection Only) Houston Texas 77030 Recruiting
University of Washington (Data Collection Only) Seattle Washington 98109 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04410796, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2025 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04410796 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →